The chemical mode of action of AptameX, Achiko's rapid Covid-19 test, strongly suggests that Omicron can be detected as reliably as any other Covid-19 variant known to dateAchiko’s highly effective, low-cost test AptameX, alongside its sister digital passporting service Teman Sehat (“Health Buddy”), … [Read more...]
Achiko’s Covid-19 DNA aptamer-based rapid testing platform update
Pilot programme in Indonesia is on track with positive results and support for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service Teman Sehat (“Health Buddy”)Approval for the second-generation AptameX test kit expected in December … [Read more...]
Achiko initiates development of dengue diagnostic test
Achiko to develop dengue fever diagnostic test by applying its DNA aptamer technology platform. This is another promising application of the technology that Achiko is already successfully using to diagnose Covid-19.The dengue virus infects about 400 million people every year and is endemic to where … [Read more...]
Achiko secures initial sales of AptameX Covid-19 diagnostic test
Achiko has received its first purchase order in Jakarta and Bali in Indonesia.The orders translates to 20’000 tests – while modest in size the order is expected to pave the way to rapid adoption by other locations and countries.After consolidating the results of the first sales, the pilot project … [Read more...]
Market Outlook and Production Plan Update for AptameX
After receiving product and registration approval from Indonesia’s Ministry of Health in August, Achiko is positioned to produce up to a million AptameX test kits in Q4 2021, and more if the supply chain allows. AptameX and Teman Sehat also well positioned in in the long term to profit greatly … [Read more...]
- 1
- 2
- 3
- …
- 11
- Next Page »